Glucocorticoid-induced Osteoporosis

• CLINICAL_TRIALS research · 2026-04-06
  Clinical Trial Update: Identifying Individuals at Risk of Glucocorticoid-Induced Impairment of Bone Disease [Phase 2]

  Phase 2 clinical trial evaluating methods to identify individuals at risk of glucocorticoid-induced osteoporosis. Sponsored by Odense Univer…

• CLINICAL_TRIALS research · 2026-03-25
  Clinical Trial Update: A Study for the Evaluation of Efficacy and Safety of Prolia® in Participants With Glucocorticoid-induced Osteoporosis in Mainland China [Phase 4]

  A Phase 4 clinical trial evaluating the efficacy and safety of Prolia (denosumab) for glucocorticoid-induced osteoporosis in Mainland China.…

• CLINICAL_TRIALS research · 2025-10-03
  Clinical Trial Update: The Role of Vitamin K2 in Preventing Glucocorticoid-Induced Bone Loss in Children With Nephrotic Syndrome [NA]

  A clinical trial sponsored by Ain Shams University is evaluating whether Vitamin K2 can prevent glucocorticoid-induced bone loss in children…

• CLINICAL_TRIALS research · 2024-11-22
  Clinical Trial Update: Romosozumab Versus Denosumab in GIOP: a 2-year Extension Study [Phase 4]

  Phase 4 extension trial comparing romosozumab versus denosumab in glucocorticoid-induced osteoporosis to assess two-year outcomes; recruitme…

• CLINICAL_TRIALS research · 2017-03-03
  Clinical Trial Update: Effects of Genistein Aglycone in Glucocorticoid Induced Osteoporosis [Phase 2, Phase 3]

  Phase 2/Phase 3 clinical trial evaluating genistein aglycone for glucocorticoid-induced osteoporosis; current status is unknown.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS research · 2014-08-06
  Clinical Trial Update: Eldecalcitol for GLucocorticoid Induced OsteopoRosIs Versus Alfacalcidol [NA]

  A clinical trial comparing eldecalcitol to alfacalcidol for glucocorticoid-induced osteoporosis; current status is unknown.